The National Quality Forum’s Measure Applications Partnership recently released guidelines on measures for the new Merit-Based Incentive Payment System and on cross-cutting issues for all federal healthcare programs.
The National Quality Forum (NQF)’s Measure Applications Partnership (MAP) recently released guidelines on measures for the new Merit-Based Incentive Payment System (MIPS) and on cross-cutting issues for all federal healthcare programs.
The recommendations, presented by MAP, for measures in these programs, reflect how well the measures address the identified program goals, as well as NQF’s prior work in identifying families of measures. Some of the dominating issues for clinician programs identified included: the new MIPS aligning all clinician measures into a single program; further alignment of clinician measures warranted with alternative payment model and hospital/facility measures; increased public reporting of clinician measures on Physician Compare; and measuring gaps in both MIPS and Medicare Shared Savings Program.
For the purpose of the review, MAP considered 60 performance measures for use in MIPS. MIPS is a program legislated by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) in CMS. MIPS combines the Physician Quality Reporting System, the Value Modifier, and the Medicare Electronic Health Record incentive program into a single program. This single program is responsible for adjusting eligible providers’ Medicare payments based on performance.
“As the US healthcare system increasingly shifts to a performance-based payment system, MAP’s role as an impartial advisor bringing stakeholders together from across the healthcare spectrum is more important than ever,” said Helen Burstin, NQF’s chief scientific officer. “The recommendations MAP made for MIPS, MSSP, and other federal healthcare programs are advancing measurement to help make better healthcare a reality for all Americans.”
Exploring in detail, the following recommendations were proposed on cross-cutting issues to HHS:
This report highlights major changes in the types of measures submitted for consideration for use and notes that this year, for the first time, more outcome measures were submitted for consideration than process measures.
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Covering antiobesity medications like semaglutide could save Medicare around $500 million annually; preliminary CDC data showed a 3% decline in the number of US overdose deaths last year; the Biden administration recently announced the first national maternal mental health strategy.
Read More
After the ACA Expanded Health Care Access, 2024 Elections May See Voters Demand Affordability
May 15th 2024At the spring conference of the New Jersey Health Care Quality Institute, speakers discussed how health policy, affordability, and transparency may play a role in voters’ decisions.
Read More